MFAP2 and cancer: Recently, a single-cell RNA sequencing study found that microfibril-associated protein-2 (MFAP2), an ECM glycoprotein that mainly functions to control ECM deposition, is associated with chemoresistance in cancer (Wei et al., 2023).